Shape Your Asset Lifecycle Early

The decisions made during development and early launch shape a pharmaceutical asset’s value for years to come. We help teams understand how early lifecycle opportunities connect and build upon one another, so they can create stronger pathways for growth and long-term value from the very beginning.

Unlock Greater Long-Term Asset Value

Many organizations take a more linear approach to early lifecycle management, focusing primarily on the next lifecycle milestone in front of them, instead of building a coordinated strategy from the outset. While individual decisions may be sound in isolation, collectively they can lead down sub-optimal routes instead of a coherent and synergistic pathway that delivers long-term value creation.

Align Strategy can guide the design of your asset’s lifecycle pathway to ensure you create, expand, and sustain value across its lifecycle – not just for the next milestone.

What Effective Early Lifecycle Management Enables

Create a Lifecycle Pathway Where Value Compounds

To realize the full potential of your asset, your lifecycle plan must work together as a coordinated system rather than a collection of disconnected activities.

Align not only supports the identification and prioritization of lifecycle opportunities, but helps orchestrate them into a cohesive plan that works in concert. We guide indication and beyond-indication initiatives across the lifecycle so each decision reinforces the next, creating value that compounds over time rather than pursuing isolated opportunities with limited strategic impact.

Maintain an Agile and Adaptable Lifecycle Plan

No drug’s lifecycle unfolds exactly as planned. The most effective organizations recognize that early lifecycle planning is not a one-time exercise, but rather requires a living, breathing approach.

Align supports your planning by building in optionality from the start. Your preferred directions is backed up with alternate pathways, clear decision points, and contingency plans, so teams can adapt confidently as competitive dynamics, clinical evidence, and organizational priorities evolve.

Align Teams Around a Shared Asset Vision

Lifecycle management is inherently a cross-functional process. A wide range of teams all influence the future direction of an asset – but they often find themselves working in isolation each with their own view of what’s best for the asset.

We help organizations to establish a shared strategic vision that aligns decision-making across functions. By creating a common understanding of lifecycle priorities and long-term objectives, teams can ensure their efforts reinforce one another and support a coherent path to value creation.

Why Align Strategy?

  • Full Lifecycle Perspective

    From early development to loss of exclusivity and beyond, our end-to-end lifecycle expertise gives us a clear understanding of the long-term consequences of today’s decisions and investments.

  • Alignment Specialists

    We are skilled at bringing different perspectives together. Through structured frameworks and facilitation, we help teams get the necessary buy-in, shared strategic vision, and alignment around their priorities.

  • Built for Uncertainty

    We build optionality into your early lifecycle planning, so you remain agile even as evidence, competition, and global markets evolve.

  • Proven LCM Frameworks

    Leverage our proprietary early LCM frameworks to move beyond abstract discussions and start making smart, aligned decisions that are grounded in a common strategic language.

A Closer Look at Our Early LCM Programs

Early Lifecycle Offering

Objective

Our Solution

Objective

Explore the Full Universe of Lifecycle Opportunities

Leave no stone unturned as you set the trajectory for the entire asset, ensuring that early development choices reinforce, rather than constrain, long-term lifecycle ambitions.

Our Solution

Indication Priortization and Sequencing

Look beyond feasibility and speed to design the strategic entry point to your lifecycle pathway and choose an order and pace of indication expansion that compounds clinical, commercial, and strategic advantage.

Beyond-Indication Tactic Prioritization and Sequencing

Apply a structured lens to identify, prioritize, and effectively sequence beyond-indication opportunities (i.e., product and solution optimization) that reinforce the asset’s defined lifecycle pathway and long-term value potential.

Objective

A Coordinated Lifecycle Strategy

Develop a pressure-tested early lifecycle management strategy, tied to a long-term vision, with clear visibility into trade-offs, risks, and dependencies, enabling more confident investment decisions and avoiding reactive lifecycle approaches.

Our Solution

Development and Validation

Transform individual lifecycle initiatives into a cohesive plan grounded in a shared strategic lens and designed to work as an integrated system that amplifies value rather than just filling a checklist.

Pressure-test

Support internal pressure-tests by reviewing existing plans and materials, gathering perspectives involved in planning, and facilitating a cross-functional workshop, helping you bring alignment while identifying any weaknesses and opportunities.

Health Check

An Align Strategy-led review of existing plans and materials followed by development of a comprehensive report providing targeted recommendations for early LCM plan optimization and proposed next steps for your team to initiate.

Objective

Create a Shared Foundation for Better Lifecycle Decision-making

Align teams around a common early lifecycle vision and create shared accountability for decision-making, enabling a consistent, repeatable application of early lifecycle thinking.

Our Solution

Embedding the Discipline

Embed early lifecycle management as a leadership-endorsed organizational discipline. Establish a shared strategic language, defined templates, frameworks, processes, and governance to support early lifecycle decision-making across assets.

Expert Training Sessions

Customized training programs that equip teams with a deep understanding of the processes behind early lifecycle strategy, supported by our proprietary frameworks.

Align Strategy Webinar

Webinar: Unlocking Durable Asset Value

In this on-demand webinar, Dr. Neal Hansen shares sharp insights on how early lifecycle management can dramatically impact a product’s long-term value – and what effective planning should look like. Discover how a strong lifecycle management plan empowers you to maximize early-stage assets and what’s at stake if you don’t have one in place.

Key Expertise In Early Lifecycle Strategy

We bring decades of experience shaping early lifecycle strategy, with deep expertise in driving long-term asset growth.

Brianna Hewson

Associate Director

Brianna, with 12+ years in healthcare, aids strategic decision-making for leading pharmaceuticals, specializing in launch and lifecycle strategy for early-stage assets.

Qualifications

MSc, Biotechnology and Enterprise (University of Manchester)

BSc, Biology (University of Massachusetts, Amherst)

Neal Hansen, PhD

Managing Director

As co-founder of Align Strategy, Neal brings over 25 years of experience advising leading pharmaceutical and biotech firms on lifecycle management and brand strategy.

Qualifications

PhD, Pharmacology (University of Cambridge)

MA (Hons), Natural Sciences (University of Cambridge)

AlignOn Early Lifecycle Management Insights

Early lifecycle management is your compass

Lifecycle Management

Early Lifecycle Management: Your Compass for Unlocking Asset Value

Developing a new pharmaceutical asset is not unlike the voyage of cargo ship: success depends on having a compass to guide you. In pharma, that compass is early lifecycle management planning.

Lifecycle Management

Going Beyond Indication Expansion: A Framework for Rethinking Lifecycle Management

Introducing a lifecycle management framework to help pharmaceutical teams go beyond indication expansion by considering the breadth, depth, and sustainability of an asset.

Lifecycle Management

How to Analyse Unmet Needs to Drive Opportunity

Capture and build on unmet needs during indication prioritisation. Avoid oversimplification to seize true opportunities for developmental assets.

Discover your asset's optimal pathway to value

Connect with one of our early lifecycle experts to learn more.